Baker Tilly Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,383	Closed	-$383K	–	297
2024 Q1	$383K	Buy	4,383 +52	+1%	+$4.54K	0.07%	308
2023 Q4	$418K	Sell	4,331 -239	-5%	-$23K	0.07%	325
2023 Q3	$404K	Buy	+4,570	New	+$404K	0.07%	306